Journal
JCI Insight
Publication Date
11-25-2025
Volume
11
Issue
1
First Page
e191266
Document Type
Open Access Publication
DOI
10.1172/jci.insight.191266
Rights and Permissions
Mackay M, Wagner CA, Pinckney A, Cohen JA, Wallace ZS, Khosroshahi A, Sparks JA, Lord S, Saxena A, Caricchio R, Kim AH, Kamen DL, Koumpouras F, Askanase AD, Smith K, Guthridge JM, Pardo G, Mao-Draayer Y, Macwana S, McCarthy S, Sherman MA, Daneshfar Hamrah S, Veri M, Walker S, York K, Tedeschi SK, Wang J, Dziubla GE, Castro M, Carroll R, Narpala SR, Lin BC, Serebryannyy L, McDermott AB, Barry WT, Goldmuntz E, McNamara J, Payne AS, Bar-Or A, Khanna D, James JA. Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial. JCI Insight. 2025 Nov 25;11(1):e191266. doi: 10.1172/jci.insight.191266. © 2025, Mackay et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Mackay, Meggan; Kim, Alfred Hj; and et al., "Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial." JCI Insight. 11, 1. e191266 (2025).
https://digitalcommons.wustl.edu/oa_4/6489
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
